The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our audited financial statements
and the notes related thereto which are included in "Item 8. Financial
Statements and Supplementary Data" of this Annual Report on Form 10-K. Certain
information contained in the discussion and analysis set forth below includes
forward-looking statements. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of many factors,
including those set forth under "Special Note Regarding Forward-Looking
Statements" and elsewhere in this Annual Report on Form 10-K.
7
Overview
We are a blank check company incorporated as a Delaware corporation and formed
for the purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination with
one or more businesses (the "Initial Business Combination").
We intend to effectuate an Initial Business Combination using cash from the
proceeds of our initial public offering (the "Public Offering") that closed on
March 15, 2022 (the "Closing Date") and the private placement warrants sold in a
private placement (the "Private Placement Warrants") that closed on the Closing
Date and from additional issuances, if any, of, our capital stock and our debt,
or a combination of cash, stock and debt.
Our business activities from inception to December 31, 2022 consisted primarily
of our preparation for our Public Offering that was completed on March 15, 2022
and, since the Closing Date, identification and evaluation of prospective
acquisition targets for an Initial Business Combination.
At December 31, 2022, we had cash of $545,655 and working capital deficit of
$148,043. Further, we expect to continue to incur significant costs in the
pursuit of our acquisition plans. We cannot assure you that our plans to
complete an Initial Business Combination will be successful.
Results of Operations
For the year ended December 31, 2022, we had net income of $593,905 which
consisted of interest income earned in the amount of $1,818,565 on cash and
funds held in the Trust Account, a gain on the over-allotment liability of
$19,432, partially offset by operating expenses totaling $904,193. In addition,
the Company recorded an income tax provision of $339,899.
For the period from June 14, 2021 (inception) through December 31, 2021, we had
a net loss of $1,430 which consisted solely of formation expenses.
Going Concern Considerations, Liquidity and Capital Resources
On March 15, 2022, we consummated the Initial Public Offering of 11,000,000
Units at a price of $10.00 per Unit, which includes the exercise by the
underwriters of the over-allotment option to purchase an additional 1,350,000
Units, generating gross proceeds of $123,500,000. Simultaneously with the
closing of the Initial Public Offering and exercise of the over-allotment
option, we consummated the sale of 5,405,000 Private Placement Warrants at a
price of $1.00 per Private Placement Warrant in a private placement to our
Sponsor, generating gross proceeds of $5,405,000.
Following the Initial Public Offering, the exercise of the over-allotment option
by the underwriters' and the sale of the Private Placement Warrants, a total of
$125,970,000 was placed in the Trust Account and as of December 31, 2022, we had
$545,655 of cash held outside of the Trust Account, after payment of costs
related to the Initial Public Offering, and available for working capital
purposes. Transaction costs amounted to $6,951,081 consisting of $1,235,000 of
underwriting fees, $4,322,500 of deferred underwriting fees payable and $597,334
of other offering costs. In addition, the Company recorded the fair value of
$776,815 for representative shares issued upon close of the Public Offering as
well as the fair value of the remaining over-allotment option of $19,432 as
offering costs.
For the year ended December 31, 2022, cash used in operating activities was
$725,102 which consisted of net income of $593,905, interest earned on
marketable securities held in the Trust Account of $1,812,882, the gain on the
change in fair value of the over-allotment liability of $19,432 and changes in
operating assets and liabilities provided $513,307 of cash from operating
activities.
For the year ended December 31, 2022, the Company used cash of $125,970,000 in
investing activities for the purchase of investments in the Trust Account
following the Initial Public Offering, the exercise of the over-allotment option
by the underwriters' and the sale of the Private Placement Warrants.
For the year ended December 31, 2022, cash from financing activities provided
$127,240,757. The Company received gross proceeds of $128,905,000 from the
Initial Public Offering, the exercise of the over-allotment option by the
underwriters' and the sale of the Private Placement Warrants. These increases
were offset by payment of the underwriting fees and offering costs of $1,235,000
and $429,243, respectively.
For the period from June 14, 2021 (inception) through December 31, 2021, cash
used in operating activities was $0 which consisted of the net loss of $1,430
offset by advances from related party of $939 and changes in operating assets
and liabilities provided $491 of cash from operating activities.
As of December 31, 2022, we had investments held in the Trust Account of
$127,782,882 principally invested in U.S. government securities. Interest income
on the balance in the Trust Account may be used by us to pay taxes, and to pay
up to $100,000 of any dissolution expenses. In March 2023, $200,050 was
withdrawn from the Trust to pay taxes.
8
At December 31, 2022, the Company had cash outside of trust of $545,655 and
working capital deficit of $148,043. Further, the Company has incurred and
expects to continue to incur significant costs in pursuit of its financing and
acquisition plans. In connection with the Company's assessment of going concern
considerations in accordance with Accounting Standards Update ("ASU") 2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," management has determined that the Company has funds that are
sufficient to fund the working capital needs of the Company until the
consummation of an initial business combination or the winding up of the Company
as stipulated in the Company's amended and restated memorandum of association.
However, management has determined that these liquidity risks, as well as if the
Company is unsuccessful in consummating an initial business combination within
15 months, or June 15, 2023 as the Company deposited $1,235,000 into the trust
account in March 2023 to fund the automatic 3-month extension, (or up to 18
months, by September 15, 2023, if the Company extends the period of time to
consummate a business combination) from the closing of the IPO, the requirement
that the Company cease all operations, redeem the public shares and thereafter
liquidate and dissolve raises substantial doubt about the ability to continue as
a going concern for the next twelve months from the issuance of this filing. The
balance sheets do not include any adjustments that might result from the outcome
of this uncertainty. The accompanying financial statements have been prepared
in conformity with generally accepted accounting principles in the United States
of America ("US GAAP"), which contemplate continuation of the Company as a going
concern.
We intend to use substantially all of the funds held in the Trust Account,
including any amounts representing interest earned on the Trust Account,
excluding the deferred underwriting commissions, to complete an initial business
combination. To the extent that capital stock or debt is used, in whole or in
part, as consideration to complete an initial business combination, the
remaining proceeds held in the Trust Account will be used as working capital to
finance the operations of the target business or businesses, make other
acquisitions and pursue growth strategies. If an initial business combination
agreement requires us to use a portion of the cash in the Trust Account to pay
the purchase price or requires us to have a minimum amount of cash at closing,
we will need to reserve a portion of the cash in the Trust Account to meet such
requirements or arrange for third-party financing.
On July 27, 2021, the Sponsor issued an unsecured promissory note to the Company
(the "Promissory Note"), pursuant to which the Company may borrow up to an
aggregate principal amount of $300,000. The Promissory Note is non-interest
bearing and payable on the earlier of (i) March 31, 2022 or (ii) the
consummation of the Initial Public Offering (the "Original Maturity Date"). On
May 20, 2022, the Company and the Sponsor amended and restated the Promissory
Note (the "Amended Note") (i) to extend the Original Maturity Date to a new
maturity date which shall be upon the earlier of the closing of the Company's
initial business combination or the Company's liquidation, and (ii) to permit
the holder of the Amended Note, in its sole discretion, to convert any or all of
the unpaid principal under the Amended Note into warrants, at a price of $1.00
per warrant, upon consummation of the Company's initial business combination. As
of December 31, 2022 and 2021, there was $125,341 outstanding under the
Promissory Note. On May 20, 2022, the Company and the Sponsor entered into the
Amended Note (i) to extend the Original Maturity Date to a new maturity date
which shall be upon the earlier of the closing of the Company's initial business
combination or the Company's liquidation, and (ii) to permit the holder of the
Amended Note, in its sole discretion, to convert any or all of the unpaid
principal under the Amended Note into Warrants, at a price of $1.00 per warrant,
upon consummation of the Company's initial business combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities which would be considered
off-balance sheet arrangements. We do not participate in transactions that
create relationships with unconsolidated entities or financial partnerships,
often referred to as variable interest entities, which would have been
established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or entered into any non-financial agreements involving assets.
Contractual Obligations
At December 31, 2022, we did not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities. In connection
with the Public Offering, we entered into an administrative support agreement
pursuant to which we agreed to pay an affiliate of the Sponsor a total of
$10,000 per month for office space, utilities and secretarial, and
administrative support services. Upon the earlier of the completion of the
Initial Business Combination and the Company's liquidation, we will cease paying
these monthly fees.
Pursuant to the Underwriting Agreement., upon the consummation of our Initial
Business Combination, we will pay the underwriters a cash fee in an amount equal
to 3.5% of the gross proceeds of the Public Offering (exclusive of any
applicable finders' fees which might become payable). No fee will be due if we
do not complete an Initial Business Combination.
9
Critical Accounting Policies and Significant Estimates
The preparation of financial statements and related disclosures in conformity
with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of the financial statements, and income and expenses during the periods
reported. Actual results could materially differ from those estimates. We have
identified the following as our critical accounting policies:
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC
Topic 260, "Earnings Per Share." Net income (loss) per share of common stock is
computed by dividing net income (loss) by the weighted average number of shares
of common stock outstanding for the period. The Company applies the two-class
method in calculating earnings per share. The remeasurement adjustment
associated with the redeemable shares of Class A Common Stock is excluded from
income (loss) per share as the redemption value approximates fair value.
The calculation of diluted income (loss) per share of common stock does not
consider the effect of the warrants issued in connection with the (i) Initial
Public Offering and (ii) the Private Placement since the exercise of the
warrants is contingent upon the occurrence of future events. . As of December
31, 2022, the warrants are exercisable to purchase 11,580,000 shares of Class A
common stock in the aggregate. As a result, diluted income (loss) per share of
common stock is the same as basic income (loss) per common stock for the periods
presented. On March 10, 2022, the Company effectuated a 1.1-for-1 share split on
the Class B common stock, resulting in an aggregate of 3,162,500 founder shares
outstanding (up to 412,500 shares of which were subject to forfeiture, of which
75,000 were forfeited, resulting in 337,500 common stock shares outstanding
subsequent to March 10, 2022). Basic net income per share of common stock
excludes the 337,500 shares subject to forfeiture from weighted average shares
outstanding between January 1, 2022 through March 10, 2022 due to the
contingency with forfeiture. Diluted net income per share of common stock
weighted average shares outstanding considers the 337,500 shares subject to
forfeiture as outstanding during the entire year ended December 31, 2022. For
the period from June 14, 2021 (inception) through December 31, 2021, the 412,500
shares subject to forfeiture were excluded from the basic and diluted weighted
average shares outstanding.
Class A common stock subject to possible redemption
The Company accounts for its shares of Class A common stock subject to possible
redemption in accordance with the guidance enumerated in ASC 480 "Distinguishing
Liabilities from Equity". Common stock subject to mandatory redemption is
classified as a liability instrument and is measured at fair value.
Conditionally redeemable common stock (including common stock that feature
redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within the
Company's control) are classified as temporary equity. At all other times,
common stock is classified as stockholders' equity. The shares of the Company's
Class A common stock feature certain redemption rights that are considered by
the Company to be outside of the Company's control and subject to the occurrence
of uncertain future events.
Fair Value of Financial Instruments
Fair value is defined as the price that would be received for sale of an asset
or paid to transfer of a liability, in an orderly transaction between market
participants at the measurement date. US GAAP establishes a three-tier fair
value hierarchy, which prioritizes the inputs used in measuring fair value. The
hierarchy gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). The determination
of fair value of the Representative Shares to the underwriter represent the most
significant accounting estimate related to the fair value of financial
instruments. The 123,500 Representative Shares have a grant date fair value of
$6.29 per share or an aggregate of $776,815. The Company measured the fair value
of the Representative Shares on the grant date of the award utilizing a
valuation model which considers certain assumptions. These assumptions include
the offering price, the marketability of the Company and the probability of
initial business combination. Upon the Initial Public Offering, such amounts
were allocated to offering costs within stockholders' equity (deficit).
Warrants
We account for warrants as either equity-classified or liability-classified
instruments based on an assessment of the warrant's specific terms and
applicable authoritative guidance in ASC 480, and FASB ASC 815, "Derivatives and
Hedging" ("ASC 815"). The assessment considers whether the warrants are
freestanding financial instruments pursuant to ASC 480, meet the definition of a
liability pursuant to ASC 480, and whether the warrants meet all of the
requirements for equity classification under ASC 815, including whether the
warrants are indexed to the Company's own common shares and whether the warrant
holders could potentially require "net cash settlement" in a circumstance
outside of the Company's control, among other conditions for equity
classification. This assessment is conducted at the time warrant issuance and as
of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity
classification, the warrants are required to be recorded as a component of
additional paid-in capital at the time of issuance. For issued or modified
warrants that do not meet all of the criteria for equity classification, the
warrants are required to be recorded at their initial fair value on the date of
issuance, and each balance sheet date thereafter. We account for our outstanding
warrants as equity-classified instruments.
10
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on the
Company's balance sheet.
© Edgar Online, source Glimpses
NUBA BRANPAR 
